on 27 Aug 2024
Last Applicant/ Owned by
One Central Square
Cardiff
CF101FS
Serial Number
97686104 filed on 21st Nov 2022
Registration Number
7484584 registered on 27th Aug 2024
Correspondent Address
Robert B.G. Horowitz, Esq.
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthm Read More
Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
N/A
N/A
Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma
N/A
N/A
Pharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
N/A
N/A
No 97686104
No Service Mark
No 091938.138
Yes
No
No
Yes
No
No
No
No
26.17.09 -
Curved line(s), band(s) or bar(s)
Status Date | Action Taken |
---|---|
27th Aug 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
27th Aug 2024 | REGISTERED-PRINCIPAL REGISTER |
11th Jun 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
11th Jun 2024 | PUBLISHED FOR OPPOSITION |
22nd May 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
09th May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
26th Oct 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
26th Oct 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
25th Oct 2023 | ASSIGNED TO LIE |
25th May 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |